Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mycobacterial membrane energetics and transport machinery is a complex system of proteins and processes essential for the survival of Mycobacterium tuberculosis (Mtb), especially within the acidic environment of host macrophages (Zhang et al., 2003). This machinery includes the electron transport chain, ATP synthase, and various transporters that collectively maintain the proton motive force (PMF), membrane potential, and internal pH homeostasis (Rao et al., 2008). The first-line anti-tuberculosis drug pyrazinamide (PZA) specifically targets this system in acidic conditions. PZA is converted into pyrazinoic acid (POA) by the bacterial enzyme pyrazinamidase; in acidic environments, POA acts as a protonophore, shuttling protons into the cell and dissipating the PMF (Gygli et al., 2017). This disruption inhibits critical membrane-associated functions, such as nutrient uptake and efflux, and depletes cellular ATP, leading to the death of both actively growing and persistent bacilli. Other drugs, such as bedaquiline and verapamil, also interact with components of this bioenergetic machinery, highlighting its importance as a multi-component therapeutic target (Chen et al., 2018). The system's vulnerability in acidic conditions makes it a unique and vital focus for shortening TB treatment and addressing drug-tolerant persisters.
Disruption of the proton motive force (PMF) and membrane potential, leading to the inhibition of membrane-bound transport systems and energy production, particularly under acidic conditions.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial membrane energetics and transport machinery.